Skip to content
Back to Guavy Wire
Stocks

Scotiabank Reaffirms Buy Rating on JNJ.US, Maintains $305 Target

Instruments
JNJ
Share

Scotiabank analyst Louise Chen has reaffirmed her buy rating for Johnson & Johnson (JNJ.US) and maintained its target price at $305.

According to TipRanks, Chen's success rate over the past year is 49.3%, with a total average return of 4.4%.

The analyst has been successful in her ratings, with TipRanks' virtual portfolio earning a positive return from the stock.

More on Stocks

Disclaimer: Guavy is a data and market intelligence provider, not an investment advisor. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Real-time market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

© 2026 Guavy Inc